Search
Displaying 311–320 of 997 results
-
Alley Morgan is from Dayton, Ohio. She has an inexhaustible love of wildlife and art. By combining those interests, she specializes in creating fun and goofy animals characters with personality and attitude.
-
“Eye of the Beholder” was initiated by two artists — both affected by retinal disease, and who are very well aware of the significance of such a contribution. For some, our artwork is an important source of income; for all, it is a deeply personal pursuit.
-
RD Fund Participates in a €75 Million Series B for SparingVision
In the PressProceeds to fund first, in-human trials of breakthrough gene-agnostic therapy products and advance CRISPR-based genome editing portfolio.
-
Foundation Fighting Blindness Makes Key Appointments to Leadership Team
Foundation NewsSeveral executives promoted to continue the advancement of the Foundation’s notable research and philanthropic efforts.
-
Youngest U.S. Blind Golfer Heading to the 2022 Vision Cup
Beacon StoriesTyler Cashman is one of six U.S. team members that have been selected to participate in the upcoming 2022 Vision Cup, an international golf competition for the blind hosted by the United States Blind Golf Association (USBGA), taking place on September 19-22, 2022.
-
Iveric Bio’s Zimura for Advanced Dry AMD Meets Endpoint in Second Phase 3 Clinical Trial
Research NewsThe company plans to seek FDA approval for the emerging therapy in first quarter of 2023
-
Belite Bio Launching Phase 3 Clinical Trial for Stargardt Disease Drug
Research NewsThe company’s drug is designed to reduce accumulation of toxins that cause vision loss.
-
Decades of Dedication Fighting for His Family and Himself
Beacon StoriesDan Day is one of over ten people in his family, spanning six generations, affected with retinitis pigmentosa (RP). So to “get off the sidelines and join the fight” for himself and his family, Dan has dedicated over 25 years of service to the Foundation Fighting Blindness.
-
ProQR Seeking to Partner Ophthalmic Programs
Research NewsThe company is halting its clinical programs for LCA10 and USH2A as it seeks a new partner
-
Funded Foundation Fighting Blindness Grants and Awards for Fiscal Year 2022 (July 1, 2021–June 30, 2022)
